Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

SurModics Inc (SRDX) Common Stock USD0.05

Sell:$51.70 Buy:$52.05 Change: $1.70 (3.40%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.70 (3.40%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.70 (3.40%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

Contact details

9924 W 74th St
United States
+1 (952) 5007000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$687.78 million
Shares in issue:
13.76 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Gary Maharaj
    President, Chief Executive Officer, Director
  • Timothy Arens
    Chief Financial Officer, Senior Vice President - Finance and Information Technology
  • Teri Sides
    Senior Vice President - Product Development, Chief Marketing Officer
  • Gordon Weber
    Senior Vice President - Legal, General Counsel, Secretary
  • Joseph Stich
    Senior Vice President, General Manager - Human Resources and In Vitro Diagnostics
  • Charles Olson
    Senior Vice President of Commercial and Business Development, Medical Devices
  • Nusrath Sultana
    Vice President - Clinical Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.